Laura J van 't Veer Selected Research

Laura J van 't Veer Research Topics

Disease

36	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
33	Neoplasms (Cancer) 03/2024 - 06/2002
7	Triple Negative Breast Neoplasms 03/2024 - 07/2016
5	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2002
4	Residual Neoplasm 03/2024 - 05/2015
2	Pathologic Complete Response 12/2023 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
2	Circulating Neoplastic Cells 01/2022 - 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021
1	Carcinogenesis 01/2016
1	Melanoma (Melanoma, Malignant) 01/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012
1	Hypersensitivity (Allergy) 03/2012
1	Telangiectasis (Telangiectasia) 03/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Familial Breast Cancer 04/2004

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 03/2024 - 12/2011
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2016
5	Estrogen ReceptorsIBA 04/2024 - 11/2017
5	Circulating Tumor DNAIBA 03/2024 - 01/2022
5	Trastuzumab (Herceptin)FDA Link 01/2024 - 07/2016
4	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2002
4	Messenger RNA (mRNA)IBA 12/2023 - 06/2002
4	InterferonsIBA 12/2023 - 01/2014
4	Tamoxifen FDA LinkGeneric 12/2022 - 11/2017
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 04/2024 - 01/2022
2	Cell-Free Nucleic AcidsIBA 03/2024 - 01/2023
2	pertuzumabIBA 01/2024 - 11/2021
2	Phenobarbital (Luminal)FDA Link 01/2024 - 12/2023
2	human ERBB2 proteinIBA 01/2024 - 07/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 11/2021
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 06/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2016 - 03/2012
1	Peptides (Polypeptides)IBA 03/2024
1	trebananibIBA 12/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2023
1	Nucleic AcidsIBA 01/2023
1	Goserelin (Zoladex)FDA Link 12/2022
1	STA 9090IBA 12/2022
1	Retinoblastoma ProteinIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	PhosphoproteinsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	CyclinsIBA 01/2022
1	Thymidine KinaseIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	Raloxifene Hydrochloride (Evista)FDA Link 08/2021
1	Docetaxel (Taxotere)FDA Link 10/2020
1	AnthracyclinesIBA 10/2020
1	Capecitabine (Xeloda)FDA Link 10/2020
1	Formaldehyde (Formol)FDA Link 11/2017
1	ParaffinIBA 11/2017
1	neratinibIBA 07/2016
1	Carboplatin (JM8)FDA LinkGeneric 07/2016
1	veliparibIBA 07/2016
1	VemurafenibIBA 01/2014
1	Cystine (L-Cystine)IBA 10/2013
1	Glutamine (L-Glutamine)FDA Link 10/2013
1	AntiportersIBA 10/2013
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2013
1	Immunoglobulins (Immunoglobulin)IBA 03/2012
1	Ataxia Telangiectasia Mutated ProteinsIBA 03/2012
1	Plasminogen Activator Inhibitor 1IBA 01/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2004
1	Insulin-Like PeptidesIBA 04/2004
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2004

Therapy/Procedure

20	Therapeutics 01/2024 - 01/2002
10	Neoadjuvant Therapy 04/2024 - 05/2015
6	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
5	Adjuvant Chemotherapy 01/2024 - 10/2006
4	Immunotherapy 04/2024 - 01/2022
3	Segmental Mastectomy (Lumpectomy) 01/2024 - 11/2017
3	Radiotherapy 01/2021 - 01/2012
2	Mastectomy (Mammectomy) 01/2019 - 11/2017
1	Investigational Therapies (Experimental Therapy) 12/2023
1	Palliative Care (Palliative Therapy) 10/2023
1	Precision Medicine 01/2023